| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenues | $1.45B+17.9% | $1.23B+17.4% | $1.05B |
| Cost of goods sold | $1.16B+17.5% | $984.0M+17.4% | $837.9M |
| Gross profit | $292.7M+19.8% | $244.4M+17.3% | $208.3M |
| Selling, general, and administrative expenses | $220.0M-28.4% | $307.3M+83.6% | $167.4M |
| Operating income (loss) | $72.7M+215.5% | -$62.9M-253.7% | $40.9M |
| Interest expense | $665K-79.7% | $3.3M+14.7% | $2.9M |
| Other expense (income), net | -$1.4M-597.1% | $279K-24.0% | $367K |
| Total other expenses (income) | -$722K-120.3% | $3.6M+10.3% | $3.2M |
| Income (loss) before income taxes | $73.4M+210.4% | -$66.5M-276.2% | $37.7M |
| Provision for income taxes | $24.5M+437.0% | $4.6M | $0 |
| Net income (loss) | $49.0M+168.9% | -$71.0M-288.3% | $37.7M |
| Less net income attributable to Guardian Pharmacy, LLC prior to the Corporate Reorganization | $0-100.0% | $22.8M-4.8% | $23.9M |
| Less net income (loss) attributable to non-controlling interests | -$261K-101.6% | $16.3M+17.6% | $13.8M |
| Net income (loss) attributable to Guardian Pharmacy Services, Inc. | $49.2M+144.7% | -$110.0M | — |
| Class A and Class B common stock [Member] | |||
| Basic | $62.39B+0.6% | $62.01B | — |
| Diluted | $63.30B+2.1% | $62.01B | — |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.